QIAGEN NV diskutieren
QIAGEN NV
WKN: A2DKCH / Symbol: QGEN / Name: QIAGEN / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
40,47 €
-0,15 %
Qiagen N.V. (NYSE: QGEN) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Ratings data for QGEN provided by MarketBeat
QIAGEN (NYSE:QGEN) was given a new $53.00 price target on by analysts at Barclays PLC. They now have an "overweight" rating on the stock.
Ratings data for QGEN provided by MarketBeat
Qiagen (NYSE:QGEN) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for QGEN provided by MarketBeat
Qiagen (NYSE:QGEN) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Ratings data for QGEN provided by MarketBeat
Qiagen (NYSE:QGEN) had its price target raised by analysts at JPMorgan Chase & Co. from $55.00 to $60.00. They now have an "overweight" rating on the stock.
Ratings data for QGEN provided by MarketBeat
Qiagen (QGEN) was given a new $43.00 price target by Robert W. Baird. They now have an "outperform" rating on the stock.
Ratings data for QGEN provided by MarketBeat
Qiagen (QGEN) had its price target lowered by JPMorgan Chase & Co. from $60.00 to $45.00. They now have an "overweight" rating on the stock.
Ratings data for QGEN provided by MarketBeat
Qiagen (QGEN) had its "buy" rating reaffirmed by Deutsche Bank Aktiengesellschaft.
Ratings data for QGEN provided by MarketBeat
Neueste Beiträge
Citigroup_Inc_ in Canadian National Railway Corp. diskutieren